Silencing of RAD51AP1 suppresses epithelial –mesenchymal transition and metastasis in non‐small cell lung cancer

ConclusionOur results revealed that RAD51AP1 silencing suppressed the EMT and metastasis of NSCLC, thereby highlighting its potential as a promising novel target for NSCLC treatment.

Source: Thoracic Cancer - July 16, 2019 Category: Cancer & Oncology Authors: Yuanyuan Wu, Huifeng Wang, Lijiao Qiao, Xiangming Jin, Hui Dong, Yan Wang Tags: ORIGINAL ARTICLE Source Type: research